The present disclosure provides a C1q binding assay. The assay disclosed here determines theC1q binding affinity of antibody by using Biolayer interferometry (BLI) technique. The disclosed method does not require any labelling of antibody, and thus is a simple and robust method for determining the binding affinity o...
[Class : 42] Scientific And Technological Services And Research And Design Relating To Pharmaceutical, Medical, Biological, Ayurvedic And Unani Research And Product Development
[Class : 35] Advertising; Business Management, Organization And Administration, Office Functions, Operation, Products, Sales And Services Of Biotechnological And Pharmaceutical, Ayurvedic And Unani Medicinal Business
View +45 more Brands for Curateq Biologics Private Limited.